APA

Hirai F., Seto T., Inamasu E., Shimokawa M., Toyokawa G., Yoshida T., Nosaki K., Takenaka T., Yamaguchi M., Takenoyama M. & Ichinose Y. (2015). Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer. : Oncology letters.

Chicago

Hirai Fumihiko, Seto Takashi, Inamasu Eiko, Shimokawa Mototsugu, Toyokawa Gouji, Yoshida Tsukihisa, Nosaki Kaname, Takenaka Tomoyoshi, Yamaguchi Masafumi, Takenoyama Mitsuhiro and Ichinose Yukito. 2015. Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer. : Oncology letters.

Harvard

Hirai F., Seto T., Inamasu E., Shimokawa M., Toyokawa G., Yoshida T., Nosaki K., Takenaka T., Yamaguchi M., Takenoyama M. and Ichinose Y. (2015). Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer. : Oncology letters.

MLA

Hirai Fumihiko, Seto Takashi, Inamasu Eiko, Shimokawa Mototsugu, Toyokawa Gouji, Yoshida Tsukihisa, Nosaki Kaname, Takenaka Tomoyoshi, Yamaguchi Masafumi, Takenoyama Mitsuhiro and Ichinose Yukito. Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer. : Oncology letters. 2015.